Supplementary Figures

18
Supplementary Figures

description

Supplementary Figures. Figure Legends. - PowerPoint PPT Presentation

Transcript of Supplementary Figures

Page 1: Supplementary Figures

Supplementary Figures

Page 2: Supplementary Figures

Figure Legends

Suppl. Figure 1. Flow cytometry analysis to monitor apoptosis levels in MCF-7 cells . As control MCF-7 cells grown in complete media were stain just with IP (1st graph) or double stained (IP and Annexin V). 2 μM of Doxorubicin was used as a positive control of apoptosis. Results are shown after treating the cells with doxorubicin in the presence or absence of FBS. The kinetics experiment after serum-deprivation shows an overall increase in apoptosis with increasing time in serum-free media.

 Suppl. Figure 2. IHC detection of secretome proteins in both normal breast tissue and breast cancer tissue obtained from Protein Atlas database. In each case, one normal breast tissue and three different breast tumors are shown.

Page 3: Supplementary Figures

Complete media + doxorubicinSerum-free media + doxorubicin 0h Serum-free media

6h Serum-free media 24h Serum-free media 48h Serum-free media 72h Serum-free media 96h Serum-free media

Complete media only IP staining Complete media

2.02%

96.48%

0.09%

1.41%

84.39%

0.70%

14.83%

0.08%

84.14%

1.20%

14.60%

0.06%

0.35%

96.54%

1.65%

1.46%

0.78%

95.30%

1.97%

1.96%

0.18%

97.52%

1.31%

1.00%

0.19%

97.35%

1.57%

0.88%

1.35%

95.45%

2.48%

0.71%

IP+ IP+, A+

IP-, A-

0.39%

97.53%

1.57%

0.51%

0.33%

95.52%

2.31%

1.85%

Suppl. Figure 1

Page 4: Supplementary Figures

CTGF

Suppl. Figure 2

Page 5: Supplementary Figures

CYR61

Page 6: Supplementary Figures

IGFBP3

Page 7: Supplementary Figures

MIF

Page 8: Supplementary Figures

MMP2

Page 9: Supplementary Figures

ANP32A

Page 10: Supplementary Figures

APEX1

Page 11: Supplementary Figures

HNRNPA2B1

Page 12: Supplementary Figures

HNRNPK

Page 13: Supplementary Figures

SUB1

Page 14: Supplementary Figures

SNRNP70

Page 15: Supplementary Figures

SSB

Page 16: Supplementary Figures

SUMO2

Page 17: Supplementary Figures

THRAP3

Page 18: Supplementary Figures

UB2L3